Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Bobis Wozowicz, Sylwia ^a,b   Galla, Melanie ^b   Alzubi, Jamal ^a,b   Kuehle, Johannes ^b   Baum, Christopher ^b   Schambach, Axel ^b,c,d   Cathomen, Toni ^a,b  

^a UNIVERSITY OF FREIBURG   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ENDONUCLEASE; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN;

ANIMAL; CELL LINE; GENE INACTIVATION; GENE TRANSFER; GENE VECTOR; GENETICS; HUMAN; K562 CELL LINE; METABOLISM; MOUSE; RETROVIRIDAE;

ANIMALS; CELL LINE; ENDONUCLEASES; GENE KNOCKOUT TECHNIQUES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; K562 CELLS; MICE; RETROVIRIDAE;

EID: 84898659454     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04656     Document Type: Article

References (59)

1. Wirt, S. E. & Porteus, M. H. Development of nuclease-mediated site-specific genome modification. Curr. Opin. Immunol. 24, 609-616 (2012).
2. Stoddard, B. L. Homing endonucleases: from microbial genetic invaders to reagents for targeted DNA modification. Structure 12, 7-15 (2011).
3. Urnov, F. D., Rebar, E. J., Holmes, M. C., Zhang, H. S. & Gregory, P. D. Genome editing with engineered zinc finger nucleases. Nat. Rev. Genet. 11, 636-646 (2010).
4. Mussolino, C. & Cathomen, T. TALE nucleases: tailored genome engineering made easy. Curr. Opin. Biotechnol. 23, 644-650 (2012).
5. Cong, L. et al.Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819-823 (2013).
6. Smith, J. et al. Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains. Nucleic Acids Res. 28, 3361-3369 (2000). (Pubitemid 30662302)
7. Bibikova, M. et al. Stimulation of homologous recombination through targeted cleavage by chimeric nucleases. Mol. Cell Biol. 21, 289-297 (2001).
8. Maeder, M. L. et al. Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. Mol. Cell. 31, 294-301 (2008). (Pubitemid 352001401)
9. Szczepek, M. et al. Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat. Biotechnol. 25, 786-793 (2007). (Pubitemid 47052189)
10. Miller, J. C. et al. An improved zinc-finger nuclease architecture for highly specific genome editing. Nat. Biotechnol. 25, 778-785 (2007). (Pubitemid 47052191)
11. Doyon, Y. et al. Enhancing zinc-finger-nuclease activity with improved obligate heterodimeric architectures. Nat. Methods 8, 74-79 (2011).
12. Händel, E. M., Alwin, S. & Cathomen, T. Expanding or restricting the target site repertoire of zinc-finger nucleases: the inter-domain linker as a major determinant of target site selectivity. Mol. Ther. 17, 104-111 (2009).
13. Carroll, D. Genome engineering with zinc-finger nucleases. Genetics 188, 773-782 (2011).
14. Perez, E. E. et al. Establishment of HIV-1 resistance in CD41 T cells by genome editing using zinc-finger nucleases. Nat. Biotechnol. 26, 808-816 (2008). (Pubitemid 351961450)
15. Holt, N. et al. Human hematopoietic stem/progenitor cells modified by zincfingernucleases targeted to CCR5 control HIV-1 in vivo. Nat. Biotechnol. 28, 839-847 (2010).
16. Benabdallah, B. F. et al. Targeted gene addition to human mesenchymal stromal cells as a cell-based plasma-soluble protein delivery platform. Cytotherapy 12, 394-399 (2010).
17. Rahman, S. H. et al. The nontoxic cell cycle modulator indirubin augments transduction of adeno-associated viral vectors and zinc-finger nuclease-mediated gene targeting. Hum. Gene Ther. 24, 67-77 (2013).
18. Höher, T., Wallace, L., Khan, K., Cathomen, T.&Reichelt, J. Highly Efficient Zinc-Finger Nuclease-Mediated Disruption of an eGFP Transgene in Keratinocyte Stem Cells without Impairment of Stem Cell Properties. Stem Cell Rev. 8, 426-434 (2012).
19. Hockemeyer, D. et al. Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-fingernucleases. Nat. Biotechnol. 27, 851-857 (2009).
20. Osiak, A. et al. Selection-independent generation of gene knockout mouse embryonic stem cells using zinc-finger nucleases. PLoS One 6, e28911 (2011).
21. Cao, F. et al. Comparison of gene-transfer efficiency in human embryonic stem cells. Mol. Imaging Biol. 12, 15-24 (2010).
22. Lombardo, A. et al. Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery. Nat. Biotechnol. 25, 1298-1306 (2007). (Pubitemid 350076515)
23. Li, H. et al. In vivo genome editing restores haemostasis in a mouse model of haemophilia. Nature 475, 217-221 (2011).
24. Händel, E. M. et al. Versatile and efficient genome editing in human cells by combining zinc-finger nucleases with adeno-associated viral vectors. Hum. Gene Ther. 23, 321-329 (2012).
25. Ellis, B. L., Hirsch, M. L., Porter, S. N., Samulski, R. J. & Porteus, M. H. Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs. Gene Ther. 20, 35-42 (2013).
26. Cornu, T. I. & Cathomen, T. Targeted genome modifications using integrasedeficient lentiviral vectors. Mol. Ther. 15, 2107-2113 (2007). (Pubitemid 350148926)
27. Cavazzana, M. Hematopoietic stem cell gene therapy: progress on the clinical front. Hum. Gene Ther. 25, 165-170 (2014).
28. Nienhuis, A.W. Development of gene therapy for blood disorders: an update. Blood 122, 1556-1564 (2013).
29. Maetzig, T., Galla, M., Baum, C. & Schambach, A. Gammaretroviral vectors: biology, technology and application. Viruses 3, 677-6713 (2011).
30. Galla, M., Will, E., Kraunus, J., Chen, L. & Baum, C. Retroviral pseudotransduction for targeted cell manipulation. Mol. Cell. 16, 309-315 (2004). (Pubitemid 39388845)
31. Voelkel, C. et al. Protein transduction from retroviral Gag precursors. Proc. Natl. Acad. Sci. USA 107, 7805-7810 (2010).
32. Maetzig, T., Baum, C. & Schambach, A. Retroviral protein transfer: falling apart to make an impact. Curr. Gene Ther. 12, 389-409 (2012).
33. Lund, A. H., Duch, M., Lovmand, J., Jørgensen, P. & Pedersen, F. S. Complementation of a primer binding site-impaired murine leukemia virusderived retroviral vector by a genetically engineered tRNA-like primer. J. Virol. 71, 1191-1195 (1997). (Pubitemid 27030291)
34. Galla, M., Schambach, A., Towers, G. J. & Baum, C. Cellular restriction of retrovirus particle-mediated mRNA transfer. J. Virol. 82, 3069-3077 (2008). (Pubitemid 351329195)
35. Galla, M. et al. Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery. Nucleic Acids Res. 39, 7147-7160 (2011).
36. Kim, Y. G., Cha, J. & Chandrasegaran, S. Hybrid restriction enzymes: zinc finger fusions to Fok I cleavage domain. Proc. Natl. Acad. Sci. USA 93, 1156-1160 (1996). (Pubitemid 26052857)
37. Davis, D. & Stokoe, D. Zinc finger nucleases as tools to understand and treat human diseases. BMC Med. 8, 42 (2010).
38. Lei, Y. et al. Gene editing of human embryonic stem cells via an engineered baculoviral vector carrying zinc-finger nucleases. Mol. Ther. 19, 942-950 (2011).
39. Doyon, Y. et al. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat. Biotechnol. 26, 702-708 (2008). (Pubitemid 351809597)
40. Meng, X., Noyes, M. B., Zhu, L. J., Lawson, N. D. & Wolfe, S. A. Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat. Biotechnol. 26, 695-701 (2008). (Pubitemid 351809594)
41. Geurts, A. M. et al. Knockout rats via embryo microinjection of zinc-finger nucleases. Science 325, 433 (2009).
42. Gaj, T., Guo, J., Kato, Y., Sirk, S. J. & Barbas, C. F. 3rd. Targeted gene knockout by direct delivery of zinc-finger nuclease proteins. Nat. Methods. 9, 805-807 (2012).
43. Li, Z. et al. Predictable and efficient retroviral gene transfer into murine bone marrow repopulating cells using a defined vector dose. Exp. Hematol. 31, 1206-1214 (2003). (Pubitemid 37510025)
44. Doyon, Y. et al. Transient cold shock enhances zinc-fingernuclease- mediated gene disruption. Nat. Methods 7, 459-460 (2010).
45. Kotani, H. et al. Improved methods of retroviral vector transduction and production for gene therapy. Hum.Gene Ther. 5, 19-28 (1994). (Pubitemid 24310531)
46. Stephenson, J. R., Tronick, S. R. & Aaronson, S. A. Temperature-sensitive mutants of murine leukemia virus. IV. Further physiological characterization and evidence for genetic recombination. J. Virol. 14, 918-923 (1974).
47. Santoni de Sio, F. R., Cascio, P., Zingale, A., Gasparini, M. & Naldini, L. Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction. Blood 107, 4257-4265 (2006). (Pubitemid 43801349)
48. Pruett-Miller, S. M., Reading, D. W., Porter, S. N. & Porteus, M. H. Attenuation of zinc finger nuclease toxicity by small-molecule regulation of protein levels. PLoS Genet. 5, e1000376 (2009).
49. Ramakrishna, S., Kim, Y. H. & Kim, H. Stability of zinc finger nuclease protein is enhanced by the proteasome inhibitor MG132. PLoS One 8, e54282 (2013).
50. Zhang, X. & Roth, M. J. Antibody-directed lentiviral gene transduction in early immature hematopoietic progenitor cells. J. Gene Med. 12, 945-955 (2010).
51. Aladjem, M. I. et al. ES cells do not activate p53-dependent stress responses and undergo p53-independent apoptosis in response to DNA damage. Curr. Biol. 8, 145-155 (1998). (Pubitemid 28091572)
52. Chuykin, I. A., Lianguzova, M. S., Pospelova, T. V. & Pospelov, V. A. Activation of DNA damage response signalling in mouse embryonic stem cells. Cell Cycle 7, 2922-2928 (2008).
53. Kustikova, O. et al. Clonal dominance of hematopoietic stem cells triggered by retroviral gene marking. Science 308, 1171-1174 (2005). (Pubitemid 40696434)
54. Cronin, J., Zhang, X. Y. & Reiser, J. Altering the tropism of lentiviral vectors through pseudotyping. Curr. Gene Ther. 5, 387-398 (2005). (Pubitemid 41052430)
55. Jang, J. E. et al. Specific and stable gene transfer to human embryonic stem cells using pseudotyped lentiviral vectors. Stem Cells Dev. 15, 109-117 (2006).
56. Di Nunzio, F., Piovani, B., Cosset, F. L., Mavilio, F.&Stornaiuolo,A. Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein. Hum. Gene Ther. 18, 811-820 (2007). (Pubitemid 47502847)
57. Schoenhals, M. et al. Efficient transduction of healthy and malignant plasma cells by lentiviral vectors pseudotyped with measles virus glycoproteins. Leukemia 26, 1663-1670 (2012).
58. Münch, R. C. et al. DARPins: an efficient targeting domain for lentiviral vectors. Mol. Ther. 19, 686-693 (2011).
59. Gallardo, H. F., Tan, C., Ory, D. & Sadelain, M. Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes. Blood 90, 952-957 (1997). (Pubitemid 27314127)